• 1. An intermolecular C–H oxidizing strategy to access highly fused carbazole skeletons from simple naphthylamines?
  Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752
• 2. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 5. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Phenylpyridines

Introduction to 2-Pyridinamine, 5-(5-fluoro-2-methylphenyl)- (CAS No. 875167-04-7)

2-Pyridinamine, 5-(5-fluoro-2-methylphenyl)-, identified by its CAS number 875167-04-7, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the class of pyridine derivatives, which are widely recognized for their diverse biological activities and potential therapeutic applications. The structural features of this molecule, particularly the presence of a fluorine substituent and a methyl group on the aromatic ring, contribute to its unique chemical properties and make it a subject of intense research interest.

The 5-(5-fluoro-2-methylphenyl) moiety in the molecular structure of 2-Pyridinamine, 5-(5-fluoro-2-methylphenyl)- plays a crucial role in modulating its pharmacological effects. Fluorine atoms are known to enhance metabolic stability and binding affinity, while the methyl group can influence electronic distribution and interactions with biological targets. These structural elements make this compound a promising candidate for further investigation in drug discovery and development.

In recent years, there has been a growing focus on developing novel small-molecule inhibitors targeting various disease pathways. 2-Pyridinamine, 5-(5-fluoro-2-methylphenyl)-, with its distinct structural characteristics, has been explored for its potential in modulating enzyme activity and receptor interactions. Preliminary studies suggest that this compound may exhibit inhibitory effects on certain kinases and other enzymes involved in cancer progression and inflammation. The fluorine substitution further enhances its bioavailability and pharmacokinetic properties, making it an attractive scaffold for medicinal chemists.

One of the most compelling aspects of 2-Pyridinamine, 5-(5-fluoro-2-methylphenyl)- is its versatility in drug design. The pyridine core provides a stable platform for further chemical modifications, allowing researchers to fine-tune its biological activity. This flexibility has led to several derivative compounds being investigated in preclinical studies for their potential therapeutic benefits. The compound's ability to interact with multiple targets makes it a valuable tool for understanding complex biological networks and developing multi-target drugs.

The synthesis of 2-Pyridinamine, 5-(5-fluoro-2-methylphenyl)- involves multi-step organic reactions that require precise control over reaction conditions and reagent selection. Advanced synthetic methodologies have been employed to ensure high yield and purity, which are critical for pharmaceutical applications. The use of fluorinated intermediates has been particularly advantageous in achieving the desired molecular structure efficiently.

Recent advancements in computational chemistry have also played a pivotal role in studying the properties of 2-Pyridinamine, 5-(5-fluoro-2-methylphenyl)-. Molecular modeling techniques have been used to predict its binding affinity to various biological targets and to design analogs with enhanced potency. These computational approaches have complemented experimental efforts by providing insights into the compound's mechanism of action and potential side effects.

The pharmacological profile of 2-Pyridinamine, 5-(5-fluoro-2-methylphenyl)- is still under active investigation, but early findings are promising. In vitro studies have demonstrated its ability to inhibit specific enzymes associated with diseases such as cancer and neurodegenerative disorders. Additionally, animal models have provided preliminary evidence of its therapeutic efficacy without significant toxicity. These results warrant further clinical trials to evaluate its safety and efficacy in human populations.

The development of novel pharmaceuticals often involves extensive collaboration between academic researchers and industry scientists. 2-Pyridinamine, 5-(5-fluoro-2-methylphenyl)- exemplifies this collaborative approach, with multiple research groups contributing to its discovery and optimization. Such partnerships accelerate the translation of laboratory findings into clinical applications, bringing new treatments to patients more quickly.

In conclusion, 2-Pyridinamine, 5-(5-fluoro-2-methylphenyl)- (CAS No.875167-04-7) represents a significant advancement in pharmaceutical chemistry. Its unique structural features and promising biological activities make it a valuable compound for drug discovery efforts aimed at treating various diseases. As research continues to uncover new therapeutic applications for this molecule, it is poised to play an important role in future medical treatments.

• 875166-87-3(2-Pyridinamine, 5-(4-fluoro-2-methylphenyl)-)
• 438585-72-9(2-Amino-5-(3,5-difluorophenyl)pyridine)
• 866620-26-0(2-Pyridinamine, 5-(4-fluorophenyl)-4-methyl-)
• 678161-98-3(1H-Pyrrol-2-amine, 4-(4-fluorophenyl)-3-(4-pyridinyl)-)
• 1110656-80-8(5-(3-fluoro-4-methylphenyl)pyridin-2-amine)
• 1249608-12-5(2-Amino-5-(2,5-difluorophenyl)pyridine)
• 1340487-51-5(3-(3,4-Difluorophenyl)-5-methylpyridin-2-amine)
• 503536-73-0(5-(4-Fluorophenyl)pyridin-2-amine)
• 866620-27-1(5-(3-Fluorophenyl)pyridin-2-amine)
• 875167-14-9(2-Pyridinamine, 5-(4-fluoro-2-methylphenyl)-4-methyl-)